Frequency of the use of biological treatment of patients with rheumatoid arthritis and ankylosing spondylitis in Lower Silesia
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Background: Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are chronic connective tissue diseases. Inadequate treatment of RA and AS results in health failure, disability and premature death. In recent years, development of immunology and genetic engineering techniques has started a new generation of drugs in the treatment of RA and AS, called biologic response modifiers or biologics. It is a very effective therapy of serious RA and AS. In many cases, they represent the only way to improve the quality of life, slowing or even arresting the development of these diseases. According to national statistics, the percentage of patients with rheumatic diseases treated with biologic treatment in Poland is less than 1.5%, and it is much lower than in Western European countries (20%).Purpose: The aim of the study was to evaluate the use of biological treatment in Lower Silesia in patients with RA and AS in the years 2006-2015, based on data obtained from the Lower Silesian Branch of the Polish National Health Fund.Results and conclusions: In the last 10 years the frequency of biological treatment of RA or AS in Lower Silesia was estimated as 2.06% of patients (in 2011) to 6.03% of patients (during the first 8 months of 2015). Biological treatment is more often used in Lower Silesia in comparison to national statistics and ranks at a similar level as in other countries of Central and Eastern Europe.
Authors and Affiliations
Wojciech Tański, Angelika Chachaj, Katarzyna Drożdż, Andrzej Szuba
Keywords
Related Articles
- EP ID EP220850
- DOI -
- Views 133
- Downloads 0
Increased percentage of CD8+CD28– suppressor lymphocytes in peripheral blood and skin infiltrates correlates with advanced disease in patients with cutaneous T-cell lymphomas
Introduction: T cells with the CD8+CD28– phenotype are CD8+ lymphocytes with regulatory function. Their increased numbers were observed in infections, autoimmune and neoplastic diseases, and in elderly healthy individual...
Znaczenie ładunku glikemicznego diety w rozwoju chorób nowotworowych
Leczenie pacjentów z chorobą nowotworową obejmuje nie tylko odpowiednią terapię farmakologiczną, rehabilitacyjną, psychologiczną, ale także dietetyczną, mającą na celu przeciwdziałanie procesowi wyniszczenia nowotworoweg...
Zaburzenie homeostazy żelaza w stwardnieniu zanikowym bocznym
Żelazo jest niezbędne wszystkim komórkom w organizmach ssaków, ale w nadmiarze może być dla nich toksyczne. Mimo znaczącego postępu wiedzy dotyczącej mechanizmów komórkowej i ogólnoustrojowej homeostazy żelaza, jaki doko...
Cu-GnRH – new gonadoliberin (GnRH) analog
Our research was concentrated about physiological and structural aspects of metal complexes with GnRH, which were synthetized by Professor Henryk Kozłowski from the Uniwersity of Wrocław. We found that copper, nickel, zi...
Mezenchymalne komórki macierzyste narzędziem terapeutycznym w regeneracji tkanek i narządów
Inżynieria tkankowa to dziedzina interdyscyplinarna, której metody stwarzają nowe możliwości regeneracji chorych i uszkodzonych tkanek, wykorzystując przy tym wiele różnych typów komórek, w tym komórki macierzyste. W i...